Haosen Ji

Haosen Ji

Auto-generated profile, based on publicly available information

Haosen Ji

Department of Neonatal Surgery, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2024 in International Immunopharmacology
Verified
Journal Article
Open access
Leiting ShenLeiting Shen
Leiting Shen
XZXiaohui Zhong
Xiaohui Zhong
HJHaosen Ji
Haosen Ji
SYSisi Yang
Sisi Yang
JJJing-Yi Jin
Jing-Yi Jin
DLDengming Lai
Dengming Lai
Neonatal necrotizing enterocolitis (NEC) is one of the most prevalent and severe intestinal emergencies in newborns. The inflammatory activation of macrophages is associated with the intestinal injury of NEC. The neuroimmune regulation mediated by α7 nicotinic acetylcholine receptor (α7nAChR) plays an important role in regulating macrophage activation and inflammation progression, but in NEC remains unclear. This study aims to explore the effect of macrophage α7nAChR on NEC. Mice NEC model were conducted with high-osmolarity formula feeding, hypoxia, and cold stimulation. The α7nAChR agonist PNU-282987 and mTOR inhibitor rapamycin were treated by intraperitoneal injections in mice. The expression and distribution of macrophages, α7nAChR, and phospho-mammalian target of rapamycin (p-mTOR) in the intestines of NEC patients and mice was assessed using immunohistochemistry, immunofluorescence, and flow cytometry. The expression of NLRP3, activated caspase-1 and IL-1β in mice intestines was detected by flow cytometry, western blot or ELISA. In vitro, the mouse RAW264.7 macrophage cell line was also cultured followed by various treatments. Expression of p-mTOR, NLRP3, activated caspase-1, and IL-1β in macrophages was determined. Macrophages accumulated in the intestines and the expression of α7nAChR in the mucosal and submucosal layers of the intestines was increased in both the NEC patients and mice. The p-mTOR and CD68 were increased and co-localized in intestines of NEC patients. In vitro, α7nAChR agonist PNU-282987 significantly reduced the increase of NLRP3, activated caspase-1, and IL-1β in macrophages. PNU-282987 also significantly reduced the increase of p-mTOR. The effect was blocked by AMPK inhibitor compound C. The expression of NLRP3, activated caspase-1, and IL-1β was inhibited after mTOR inhibitor rapamycin treatment. In NEC model mice, PNU-282987 reduced the expression of p-mTOR, NLRP3, activated caspase-1, and IL-1β in the intestine. Meanwhile, rapamycin significantly attenuated NLRP3 activation and the release of IL-1β. Moreover, the proportion of intestinal macrophages and intestinal injury decreased after PNU-282987 treatment. Macrophage α7nAChR activation mitigates NLRP3 inflammasome activation by modulating mTOR phosphorylation, and subsequently alleviates intestinal inflammation and injury in NEC.

19 November 2025 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
MZMeng Zhang
Meng Zhang
JWJudith Wellens
Judith Wellens
JZJianhui Zhao
Jianhui Zhao
HJHaosen Ji
Haosen Ji
JSJing Sun
Jing Sun
XLXue Li
Xue Li
INTRODUCTION: Comorbidities between mental disorders and irritable bowel syndrome (IBS) have been widely reported, yet associations between mental wellbeing and IBS, particularly regarding underlying genetic modification and proteomic signatures, remain underexplored. METHODS: This prospective cohort study analyzed 75,842 IBS-free participants aiming to investigate the prospective association between mental wellbeing and the risk of IBS in UK Biobank. Mental wellbeing was assessed through life satisfaction, positive affect, neuroticism, and depressive/anxiety symptoms. Cox models evaluate the hazard ratio (HR) for mental wellbeing and plasma proteome in relation to incident IBS during follow-up. Proteomic profiling identified mental wellbeing-associated proteins, with pathway enrichment analysis revealing biological mechanisms. Mediation and Mendelian randomization analyses further examine intermediate pathways and causality. RESULTS: With a 12.4-year follow-up period, 1,400 cases of incident IBS were documented. Better mental wellbeing mitigated IBS risk dose-dependently (low risk group: HR, 0.37; 95% confidence interval [CI]: 0.31–0.43). Higher life satisfaction (HR, 0.41; 95% CI: 0.30–0.56) and positive affect (HR, 0.50; 95% CI: 0.41–0.62) were inversely associated with IBS risk, whereas neuroticism (HR, 2.35; 95% CI: 1.92–2.88) and depressive/anxiety symptoms (HR, 3.09; 95% CI: 2.17–4.42) increased the risk. Findings remained consistent in across prevalent IBS and IBS subtypes. Mental wellbeing effects were independent of genetic predisposition. Mediation analyses revealed about 27% of protective effect of mental wellbeing were mediated through reduced depression and anxiety. Mendelian randomization supports causal protective effects of positive mental wellbeing on IBS. Proteomic profiling identified mental wellbeing-associated proteins mainly enriched in cytokine-cytokine receptor interactions. Chromogranin A and gastrin emerged as key protein biomarkers, showing significant associations with both mental wellbeing components and IBS risk. DISCUSSION: Our study demonstrates that enhanced mental wellbeing confers substantial protection against IBS development, highlighting psychological interventions as potential primary prevention strategies.

1 January 2025 in Stem Cells International
Verified
Journal Article
Open access
HJHaosen Ji
Haosen Ji
ZXZheming Xu
Zheming Xu
LSLeiting Shen
Leiting Shen
SYSisi Yang
Sisi Yang
JJJingyi Jin
Jingyi Jin
JTJinfa Tou
Jinfa Tou
Background: Mesenchymal stem cells (MSCs) inhibit macrophage inflammatory response and alleviate intestinal inflammation. However, the role of MSCs in Hirschsprung‐associated enterocolitis (HAEC) remains uncertain. This study aims to investigate the effects of MSCs on HAEC and the mechanisms related to macrophages and MSCs. Methods: Immunofluorescence was used to measure CD68 and p‐AKT in colonic tissues of HSCR patients with HAEC. Ednrb −/− mice was used as HSCR model. The proportion of colonic tissue macrophages in WT and Ednrb −/− mice was assessed by flow cytometry. The colonic tissues injury was evaluated with HE staining and the survival curves of mice were recorded. In vitro, macrophage‐induced enterocyte death was induced by lipopolysaccharide (LPS). MSCs, MSC derived exosomes, miR‐223, or MK2206 were added to macrophages, and the levels of miR‐223 in macrophages after exosome treatment were measured by RT‐qPCR. Flow cytometry was used to assess enterocyte death, western blot was performed to measure p‐AKT expression in macrophages, and enzyme‐linked immunosorbent assay (ELISA) was used to detect IL‐1β concentration in macrophage supernatants and serum of Edrnb −/− mice. Results: Increased expression of CD68 and p‐AKT was observed in the colonic tissues of HAEC patients. Colonic instillation of MSCs derived exosomes significantly reduce the inflammatory score of colonic tissues and prolong the survival time of HAEC mice. In vitro, LPS‐stimulated macrophages induce the phosphorylation of AKT and enterocyte death. Stimulation of macrophages with MSC‐derived exosomes increased the content of miR‐223. MSC‐derived exosomes, miR‐223 and MK2206 significantly reduce macrophage‐induced enterocyte death, attenuated AKT phosphorylation in macrophages, and decreased IL‐1β concentration in macrophage supernatants. Conclusion: Macrophages accumulate in colonic tissues during HAEC and inflammatory macrophages drive enterocyte death. MSCs derived exosomes reduce enterocyte death by suppressing AKT phosphorylation and IL‐1β secretion via miR‐223, and subsequently mitigate HAEC in mice. These findings suggest that MSC‐derived exosomes, particularly those enriched in miR‐223, may serve as a promising therapeutic strategy for the prevention or treatment of HAEC.